Managing Non-Communicable Disease Control Programmes

Learn to design, measure and defend your organisation's approach to non-communicable disease control.

📍 Istanbul🗓️ 5 training days📚 4 modules🎓 Accredited certificate
5intensive training days
4scientific modules
8training sessions
32detailed points

Course Overview

Clinical staff will work around a process for non-communicable disease control that obstructs care, and they will be right to. Accreditation bodies assess this area of health and pharmaceutical services on documented evidence of consistent practice. The version of this strand of health and pharmaceutical services described in the manual and the version practised on the floor tend to diverge over time. The professional literature on non-communicable disease control converges on a small set of controls that reliably work. It is designed for mixed groups, so that the practice within health and pharmaceutical services is examined from more than one functional angle. Cases are chosen to expose the trade-offs in the wider health and pharmaceutical services agenda rather than to illustrate ideal conditions. It concentrates on the parts of non-communicable disease control that determine outcomes and treats the rest proportionately. Participants gain a realistic view of what the practice within health and pharmaceutical services costs and what it returns. Work concludes with a self-assessment of this strand of health and pharmaceutical services that participants can repeat annually.

Expected Learning Outcomes

01

Align non-communicable disease control with the wider objectives of the clinical service rather than optimising it in isolation.

02

Apply root cause analysis to adverse events involving non-communicable disease control.

03

Build informed consent and ethics practice into non-communicable disease control.

04

Assess and control infection risk associated with non-communicable disease control.

05

Measure patient experience of non-communicable disease control and act on what it shows.

06

Assess the current state of non-communicable disease control against a structured set of criteria rather than impressions.

07

Plan the handover of non-communicable disease control so that capability is not lost when key staff move on.

Who Should Attend

01

Nursing managers and clinical supervisors delivering non-communicable disease control.

02

Quality and patient safety officers monitoring non-communicable disease control.

03

Anyone whose accountability for non-communicable disease control exceeds their current formal training in it.

04

Regulatory affairs specialists handling non-communicable disease control.

05

Finance managers costing services delivered through non-communicable disease control.

06

Coordinators responsible for keeping records and documentation of non-communicable disease control current.

Course Modules

01

Non-communicable disease control: cost, efficiency and sustainability of the service

2 sessions · 8 points

Session 1Infection risk created by non-communicable disease control

  • Check that records of non-communicable disease control answer the questions likely to be asked.
  • Check that consent processes within non-communicable disease control are genuinely informed.
  • Decide what will be stopped to create capacity for non-communicable disease control.
  • Define acceptance criteria for non-communicable disease control in advance.

Session 2What patients actually experience during non-communicable disease control

  • Audit non-communicable disease control by observing practice, not by reading policy.
  • Reduce the variation in how non-communicable disease control is carried out between teams.
  • Establish the boundary of non-communicable disease control and record what sits outside it.
  • Agree what will be standardised in non-communicable disease control and what will not.
02

Non-communicable disease control: medication and treatment safety

2 sessions · 8 points

Session 1Matching staffing on non-communicable disease control to real demand

  • Confirm patient data handled within non-communicable disease control meets confidentiality obligations.
  • Assemble the accreditation evidence pack for non-communicable disease control.
  • Plan continuity of non-communicable disease control during surge and outbreak conditions.
  • Define escalation criteria for deterioration detected through non-communicable disease control.

Session 2Keeping supply and cold chain reliable for non-communicable disease control

  • Confirm that contractual obligations around non-communicable disease control are understood.
  • Close out actions on non-communicable disease control rather than leaving them open indefinitely.
  • Build medication safety checks into non-communicable disease control at the point of highest risk.
  • Draft the minimum viable clinical protocol for non-communicable disease control.
03

Non-communicable disease control: confidentiality, consent and ethics

2 sessions · 8 points

Session 1The paperwork for non-communicable disease control that is actually needed

  • Select quality indicators for non-communicable disease control that measure outcome rather than activity.
  • Map the clinical workflow for non-communicable disease control as it is actually performed.
  • Match staffing levels on non-communicable disease control to measured demand across the week.
  • Reduce unwarranted variation in non-communicable disease control between shifts and sites.

Session 2Closing out non-communicable disease control and capturing what was learned

  • Confirm competence and continuing development for staff delivering non-communicable disease control.
  • Set escalation thresholds for non-communicable disease control that work out of hours.
  • Close the loop: confirm changes to non-communicable disease control improved the indicator they targeted.
  • Check that non-communicable disease control still works when volumes rise unexpectedly.
04

Non-communicable disease control: clinical process design and workflow

2 sessions · 8 points

Session 1Who answers for non-communicable disease control, and to whom

  • Confirm that reporting on non-communicable disease control reaches the people who can act.
  • Define the trigger that would require non-communicable disease control to be redesigned.
  • Agree the indicators that will show whether non-communicable disease control is improving.
  • Identify infection transmission risks created by non-communicable disease control and control them.

Session 2The evidence assessors will ask for on non-communicable disease control

  • Test the procedure for non-communicable disease control against a realistic scenario.
  • Rank the weaknesses in non-communicable disease control by consequence rather than by ease of fixing.
  • Confirm licensing and regulatory requirements applying to non-communicable disease control are met.
  • Measure patient experience of non-communicable disease control and feed it back to the team.

Choose the package that suits you

Silver Package

At least 3 people

USD1,250
  • Workshop or Program Participation
  • Airport Transfers
  • Customized Badge
  • Expert Mentorship (Private Sessions)
  • Supervision & Secretarial Services
  • Accredited Certificate of Participation
  • Complete Training Kit
  • Coffee Break
  • Closing Ceremony

Gold Package

At least 3 people

USD1,850
  • 5-night stay in a 5-star hotel
  • Workshop or Program Participation
  • Airport Transfers
  • Customized Badge
  • Expert Mentorship (Private Sessions)
  • Supervision & Secretarial Services
  • Accredited Certificate of Participation
  • Complete Training Kit
  • Coffee Break
  • Closing Ceremony

Complete your registration

We will contact you within one business day to confirm.